Free. Unsubscribe any time.
RECURSION PHARMACEUTICALS, INC. (RXRX)
RECURSION PHARMACEUTICALS, INC. filed 42 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 5 reporting owners, covering 46 transactions and 3,006,560 shares. None carries the SEC's AFF10B5ONE flag; all 42 name a plan in a footnote. 7 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2026-09-10, came 8 days after the one before it (2026-09-02) and reports 1 transaction against 1 in the filing before it.
- The sales it reports total 22,408 shares, 7,592 fewer than the 30,000 in the filing before it.
- Its 42 plan statements rank 132nd of the 483 companies the register carries in Delaware, its state of incorporation.
- Of the 10 companies the register lists beside it in its industry, 2 have more plan statements on file than it and 8 have fewer.
- Its 42 filings on file run from 2025-01-13 to 2026-09-10, and state 7 plan adoption dates, from 2023-12-27 to 2026-03-03.
Trades in RECURSION PHARMACEUTICALS, INC. 46
- Gibson Christopher — 2025-01-08 · S · 20,000 shares
- Gibson Christopher — 2025-01-10 · S · 20,000 shares
- Gibson Christopher — 2025-02-05 · S · 20,000 shares
- Gibson Christopher — 2025-02-06 · S · 20,000 shares
- Gibson Christopher — 2025-03-05 · S · 20,000 shares
- Gibson Christopher — 2025-03-06 · S · 20,000 shares
- Gibson Christopher — 2025-03-27 · S · 138,574 shares
- Gibson Christopher — 2025-08-11 · S · 500,300 shares
- Gibson Christopher — 2025-08-11 · S · 100,000 shares
- Gibson Christopher — 2025-08-11 · S · 17,875 shares
- Gibson Christopher — 2025-08-26 · S · 100,000 shares
- Gibson Christopher — 2025-09-10 · S · 100,000 shares
Adoption dates in RECURSION PHARMACEUTICALS, INC. 7
- 2023-12-27 — stated in 3 filings
- 2024-12-19 — stated in 1 filing
- 2025-05-12 — stated in 21 filings
- 2025-08-31 — stated in 8 filings
- 2025-09-22 — stated in 4 filings
- 2025-09-30 — stated in 3 filings
- 2026-03-03 — stated in 2 filings
Results prints in RECURSION PHARMACEUTICALS, INC. 7
- 2025-02-28
- 2025-05-05
- 2025-08-05
- 2025-11-05
- 2026-02-25
- 2026-05-06
- 2026-08-05
Trades before a print in RECURSION PHARMACEUTICALS, INC. 3
- 1 day before the 2025-11-05 print — 2025-11-04 · S · Gibson Christopher · 40,000 shares
- 1 day before the 2026-05-06 print — 2026-05-05 · S · Borgeson Blake · 30,000 shares
- 1 day before the 2026-08-05 print — 2026-08-04 · S · Borgeson Blake · 30,000 shares
- 6 days before the 2026-02-25 print — 2026-02-19 · S · Gibson Christopher · 40,000 shares
- 7 days before the 2026-02-25 print — 2026-02-18 · S · Taylor Ben R · 13,426 shares
- 13 days before the 2025-11-05 print — 2025-10-23 · S · Gibson Christopher · 100,000 shares
- 14 days before the 2026-05-06 print — 2026-04-22 · S · Gibson Christopher · 40,000 shares
- 21 days before the 2026-02-25 print — 2026-02-04 · S · Gibson Christopher · 40,000 shares
- 22 days before the 2025-02-28 print — 2025-02-06 · S · Gibson Christopher · 20,000 shares
- 22 days before the 2026-02-25 print — 2026-02-03 · S · Borgeson Blake · 220,000 shares
- 23 days before the 2025-02-28 print — 2025-02-05 · S · Gibson Christopher · 20,000 shares
- 26 days before the 2025-11-05 print — 2025-10-10 · S · Gibson Christopher · 100,000 shares
Interval to RECURSION PHARMACEUTICALS, INC.’s next reported results date
How the interval and sources are counted →
- 3within 5 days
- 5within 10 days
- 1shortest, days
- 2no later print
- Gibson Christopher 2025-11-04 · S · 1 day before the 2025-11-05 print · Chief Executive Officer
- Taylor Ben R 2026-02-18 · S · 7 days before the 2026-02-25 print · Chief Financial Officer
- Gibson Christopher 2026-02-19 · S · 6 days before the 2026-02-25 print
- Borgeson Blake 2026-05-05 · S · 1 day before the 2026-05-06 print
- Borgeson Blake 2026-08-04 · S · 1 day before the 2026-08-05 print
Adoption dates RECURSION PHARMACEUTICALS, INC. states
- 2023-12-27 in 3 filings
- 2024-12-19 in 1 filing
- 2025-05-12 in 21 filings
- 2025-08-31 in 8 filings
- 2025-09-22 in 4 filings
- 2025-09-30 in 3 filings
- 2026-03-03 in 2 filings
Filing text: “10b5-1 trading plan adopted by the Reporting Person on December 27, 2023”
Reported results dates on file
- 2025-02-28
- 2025-05-05
- 2025-08-05
- 2025-11-05
- 2026-02-25
- 2026-05-06
- 2026-08-05
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.